Devyser Diagnostics
Develops DNA testing kits for hereditary diseases, oncology, and post-transplant monitoring.
DVYSR | ST
Overview
Corporate Details
- ISIN(s):
- SE0016588867 (+1 more)
- LEI:
- 549300RV4Z2K3360CK30
- Country:
- Sweden
- Address:
- Instrumentvägen 19, 126 53 Hägersten
- Website:
- https://devyser.com/
- Sector:
- Manufacturing
Description
Devyser Diagnostics develops, manufactures, and sells diagnostic kits and solutions for advanced DNA testing. The company's products are designed for use in clinical laboratories to streamline workflows and enable rapid, accurate diagnosis. Its portfolio covers complex testing areas including hereditary diseases, oncology, and post-transplant monitoring. Key offerings include Next-Generation Sequencing (NGS) and PCR-based test kits with integrated software for applications such as chimerism analysis and non-invasive prenatal testing. In addition to its kit-based business, Devyser operates genomic laboratories that provide genetic testing services to healthcare providers and biopharmaceutical companies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Devyser Diagnostics filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Devyser Diagnostics
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Devyser Diagnostics via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-14 | Mia Arnhult | Other | Buy | 7,000 | 745,290.00 SEK |
Peer Companies
